Industry | 制造业 | ||||||||||||||||||||||||
Company Introduction | 公司是一家研发驱动型的高新技术企业,设立以来一直专注于通用电子测试测量仪器的开发和技术创新,紧紧抓住电子工业的发展和需求变化,研发出具有自主核心技术的数字示波器、波形和信号发生器、频谱分析仪、矢量网络分析仪等产品,具备国内先进通用电子测试测量仪器研发、生产和销售能力,为国内通用电子测试测量仪器中高端产品实现国产化和进口替代提供支持力量。公司自主品牌“SIGLENT”已经成为全球知名的通用电子测试测量仪器品牌,产品销往全球80多个国家和地区,是国内技术领先的通用电子测试测量仪器企业之一。 通用电子测试测量仪器融合了多学科、多领域最先进的技术,由同时代最优异的电子元器件架构而成,具有“高科技、高性能、高价值”的特征。基于产品技术含量高的特性,公司将创新研发作为发展的核心驱动力,十分注重技术研发和产品创新,通过持续的研发投入和技术团队建设,打造了具有持续创新能力的研发平台,实现了技术的自主研发和产品创新。公司建立了广东省科技厅认定的“广东省高端通信测量仪器工程技术研究中心”、广东省工业和信息化厅认定的“广东省鼎阳科技工业设计中心”和中国合格评定国家认可委员会(CNAS)批准的“测量实验室”,先后承担国家部委、深圳市和宝安区研发及产业化项目合计7项,现有专利111项(其中发明专利57项)和软件著作权24项。公司2017年、2018年连续两年被评为深圳市宝安区创新百强企业,公司技术和专利曾荣获“深圳市科技进步奖(技术开发类)二等奖”和“中国专利优秀奖”等殊荣。 公司依托良好的产品创新能力和稳定的产品品质,与示波器领域国际领导企业之一力科和全球电商平台亚马逊建立了稳定的业务合作关系。公司建立了稳定的全球销售体系,产品主要销售区域为北美、欧洲和亚洲电子相关产业发达的地区,获得了涵盖通讯、半导体、汽车电子、航空航天和国防、医疗、计算机、家电等电子工业领域和教育等领域数量众多的国内外知名企业和教育机构的认可,其中国内知名客户包括华为、比亚迪、富士康、大疆、TCL、创维、OPPO、迈瑞医疗、科大讯飞、清华大学、北京大学、中科院大学、浙江大学、武汉大学、南京大学、东南大学等。 2007年6月5日,汤勇军、邵海涛、秦轲共同签署《深圳市鼎阳科技有限公司章程》,约定共同出资设立鼎阳有限,注册资本50万元。2007年6月13日,深圳工商行政管理局核发了注册号为4403011267356的《企业法人营业执照》。 根据致同会计师事务所(特殊普通合伙)于2019年10月25日出具的致同专字(2019)第441ZB6904号《审计报告》,将截至2019年5月31日经审计的公司净资产人民币91,991,728.99元按1:0.869643的比例折为股份有限公司的发起人股份80,000,000股,每股面值1元,剩余部分11,991,728.99元作为股份有限公司的资本公积。2019年11月15日,公司取得深圳市市场监督管理局颁发的统一社会信用代码为91440300662687585F的《企业法人营业执照》。 | ||||||||||||||||||||||||
Main Business | 通用电子测试测量仪器的研发、生产和销售。 | ||||||||||||||||||||||||
Legal Representative | 秦轲 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 刘厚军 | ||||||||||||||||||||||||
Solicitors | 上海市锦天城律师事务所 | ||||||||||||||||||||||||
Auditors | 致同会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0755-26616618 | ||||||||||||||||||||||||
Fax No | 0755-26616617 | ||||||||||||||||||||||||
Website | www.siglent.com | ||||||||||||||||||||||||
zqb@siglent.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 01/12/2021 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.980 | ||||||||||||||||||||||||
DPS(RMB)* | ¥ 0.880 | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 9.812 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 1.510B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |